These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9013993

  • 1. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.
    Nakajima A, Hirose S, Yagita H, Okumura K.
    J Immunol; 1997 Feb 01; 158(3):1466-72. PubMed ID: 9013993
    [Abstract] [Full Text] [Related]

  • 2. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
    Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K.
    Eur J Immunol; 1995 Nov 01; 25(11):3060-9. PubMed ID: 7489744
    [Abstract] [Full Text] [Related]

  • 3. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Nov 01; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 4. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H, Weill B, Fournier C, Batteux F.
    Eur J Immunol; 2003 Jun 01; 33(6):1603-12. PubMed ID: 12778478
    [Abstract] [Full Text] [Related]

  • 5. Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand.
    Nakajima A, Hirai H, Kayagaki N, Yoshino S, Hirose S, Yagita H, Okumura K.
    J Autoimmun; 2000 Mar 01; 14(2):151-7. PubMed ID: 10677246
    [Abstract] [Full Text] [Related]

  • 6. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A.
    Int Immunol; 2004 Jul 01; 16(7):937-46. PubMed ID: 15148287
    [Abstract] [Full Text] [Related]

  • 7. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 8. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 Jun 15; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 9. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T, Hasegawa K, Sasaki Y, Mori T, Adachi C, Maeda K.
    Nephrol Dial Transplant; 2007 Nov 15; 22(11):3131-8. PubMed ID: 17670770
    [Abstract] [Full Text] [Related]

  • 10. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN, Minoprio P, Avrameas S, Ternynck T.
    Immunology; 1995 May 15; 85(1):26-32. PubMed ID: 7635519
    [Abstract] [Full Text] [Related]

  • 11. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun 15; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 12. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 13. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG, Kaser SB, Beller DI.
    J Immunol; 1998 Dec 15; 161(12):6878-84. PubMed ID: 9862720
    [Abstract] [Full Text] [Related]

  • 14. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 15; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 15. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A, Kodera S, Ohtsuji N, Nakamura K, Tsurui H, Kinoshita K, Nishimura H, Shirai T, Hirose S.
    Int Immunol; 2007 Feb 15; 19(2):175-83. PubMed ID: 17189592
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q, Mumtaz IM, Khodadadi L, Radbruch A, Hoyer BF, Hiepe F.
    Ann Rheum Dis; 2013 Dec 15; 72(12):2011-7. PubMed ID: 24114925
    [Abstract] [Full Text] [Related]

  • 17. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
    Kaliyaperumal A, Michaels MA, Datta SK.
    J Immunol; 1999 May 15; 162(10):5775-83. PubMed ID: 10229810
    [Abstract] [Full Text] [Related]

  • 18. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.
    Finck BK, Chan B, Wofsy D.
    J Clin Invest; 1994 Aug 15; 94(2):585-91. PubMed ID: 8040314
    [Abstract] [Full Text] [Related]

  • 19. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C, Frey S, Wellmann U, Urbonaviciute V, Herrmann M, Amann K, Schett G, Winkler T, Voll RE.
    Eur J Immunol; 2011 Jul 15; 41(7):2107-12. PubMed ID: 21484784
    [Abstract] [Full Text] [Related]

  • 20. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
    Carteron NL, Schimenti CL, Wofsy D.
    J Immunol; 1989 Mar 01; 142(5):1470-5. PubMed ID: 2521880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.